跳至主要内容
临床试验/NCT07169149
NCT07169149尚未招募不适用

Study of the Prevalence and Patterns of Drug Resistance of Mycobacterium Tuberculosis Using GeneXpert (MTB/RIF) and Xpert (MTB/XDR) Assays

Sohag University1 个研究点 分布在 1 个国家目标入组 250 人开始时间: 2025年10月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
250
试验地点
1
主要终点
Detection of number of cases resistant to Rifampicin and other anti- TB drugs

研究概览

简要总结

Tuberculosis is a major cause of ill health and one of the leading causes of death worldwide. Early, rapid and accurate diagnosis of all TB patients and prompt treatment with any form of drug-susceptible or drug resistant TB is fundamental. Identifying the pattern of drug resistance will ensure that the most effective therapy can be selected. The aim of this study is to assess the prevalence and patterns of drug resistance of mycobacterium tuberculosis and to detect the possible risk factors associated with resistant cases.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Cross Sectional

入排标准

年龄范围
12 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • geneXpert positive patients in pulmonary and extrapulmonary cases

排除标准

  • age below 12 years

结局指标

主要结局

Detection of number of cases resistant to Rifampicin and other anti- TB drugs

时间窗: within 6 months of starting treatment

Using of GeneXpert (MTB/RIF) and Xpert (MTB/XDR) assays to detect resistance to Rifampicin and other anti -TB drugs among TB positive cases

次要结局

  • Detection of common Risk factors associated with resistant cases(within 6 months of starting treatment coarse)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Omnia Abdelazim Mohamed

chest specialist

Sohag University

研究点 (1)

Loading locations...

相似试验